Amedeo Smart

Free Medical Literature Service




  Free Subscription

Articles published in
J Clin Invest
    August 2022
    Does immune destruction drive all forms of bone marrow failure?
    J Clin Invest. 2022;132.
    >> Share

    June 2022
  2. LIN Q, Wu L, Chatla S, Chowdhury FA, et al
    Hematopoietic stem cell regeneration through paracrine regulation of the Wnt5a/Prox1 signaling axis.
    J Clin Invest. 2022;132.
    >> Share

  3. CASADO JA, Valeri A, Sanchez-Dominguez R, Vela P, et al
    Upregulation of NKG2D ligands impairs hematopoietic stem cell function in Fanconi anemia.
    J Clin Invest. 2022 Jun 7. pii: 142842. doi: 10.1172/JCI142842.
    >> Share

  4. BEDIN M, Boyer O, Servais A, Li Y, et al
    Human C-terminal CUBN variants associate with chronic proteinuria and normal renal function.
    J Clin Invest. 2022;132.
    >> Share

    March 2022
    The hematopoietic saga of clonality in sickle cell disease.
    J Clin Invest. 2022;132.
    >> Share

    February 2022
  6. LIGGETT LA, Cato LD, Weinstock JS, Zhang Y, et al
    Clonal hematopoiesis in sickle cell disease.
    J Clin Invest. 2022;132.
    >> Share

    January 2022
  7. GUAN Y, Hasipek M, Jiang D, Tiwari AD, et al
    Eltrombopag inhibits TET dioxygenase to contribute to hematopoietic stem cell expansion in aplastic anemia.
    J Clin Invest. 2022 Jan 27. pii: 149856. doi: 10.1172/JCI149856.
    >> Share

    June 2021
  8. ZHANG J, Qin Y, Martinez M, Flores-Bellver M, et al
    HIF-1alpha and HIF-2alpha redundantly promote retinal neovascularization in patients with ischemic retinal disease.
    J Clin Invest. 2021;131.
    >> Share

  9. KOLEINI N, Shapiro JS, Geier J, Ardehali H, et al
    Ironing out mechanisms of iron homeostasis and disorders of iron deficiency.
    J Clin Invest. 2021;131.
    >> Share

    April 2021
  10. DOERFLER PA, Sharma A, Porter JS, Zheng Y, et al
    Genetic therapies for the first molecular disease.
    J Clin Invest. 2021;131.
    >> Share

  11. MATTE A, Federti E, Kung C, Kosinski PA, et al
    The pyruvate kinase activator mitapivat reduces hemolysis and improves anemia in a beta-thalassemia mouse model.
    J Clin Invest. 2021 Apr 6. pii: 144206. doi: 10.1172/JCI144206.
    >> Share

    January 2021
  12. NEILL US
    A conversation with Griffin Rodgers.
    J Clin Invest. 2021;131.
    >> Share

    October 2020
  13. PFEFFERLE M, Ingoglia G, Schaer CA, Yalamanoglu A, et al
    Hemolysis transforms liver macrophages into antiinflammatory erythrophagocytes.
    J Clin Invest. 2020;130:5576-5590.
    >> Share

    May 2020
  14. GAVRIILAKI E, Brodsky RA
    Complementopathies and precision medicine.
    J Clin Invest. 2020;130:2152-2163.
    >> Share

  15. FRANCIS RO, D'Alessandro A, Eisenberger A, Soffing M, et al
    Donor glucose-6-phosphate dehydrogenase deficiency decreases blood quality for transfusion.
    J Clin Invest. 2020;130:2270-2285.
    >> Share

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016